Atlas Trials

Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma

Clinical trial NCT00110006 · WITHDRAWN

Trial details

NCT number
NCT00110006
Sponsor
Case Comprehensive Cancer Center
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Lymphoma
Start date
2004-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.